Sanofi and GSK close to reaching $624 Million U.K. Vaccine Deal
Sanofi and GlaxoSmithKline are close to reaching a 500 million-pound ($624 million) deal to supply the United Kingdom government with
Read more
Deals
AstraZeneca to supply up to 400 million doses of Oxford’s vaccine free
AstraZeneca has come to an agreement with the European Inclusive Vaccines Alliance (IVA), initiated by Germany, France, Italy and the
Read more
AstraZeneca reaches $750m agreement with CEPI for Oxford COVID-19 vaccine
British pharmaceutical company AstraZeneca has reached a landmark $750 million agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and the
Read more
Moderna and Lonza partner up to manufacture COVID-19 vaccine
Moderna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read more
AstraZeneca and Oxford University agree to globalise COVID-19 vaccine
UK-headquartered AstraZeneca and Oxford University announced an agreement to develop and distribute the university’s future recombinant adenovirus vaccine to prevent
Read more
Pharma giants Sanofi and GSK team up to develop COVID-19 vaccine
Pharma giants Sanofi and GSK have entered into an unprecedented partnership to battle COVID-19. The leading pharmaceutical companies have agreed
Read more
Dynavax and Clover to collaborate for Coronavirus (COVID-19) Vaccine
Dynavax and Clover Biopharmaceuticals have announced a research collaboration to evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant. US
Read more
US military strikes deal for Gilead’s remdesivir COVID-19 treatment
Gilead’s remdesivir COVID-19 treatment will be made available to the US Military. The U.S. Army Medical Research and Development Command
Read more
Gilead to acquire immuno-oncology company Forty Seven for $4.9 Billion
Gilead to acquire clinical-stage immuno-oncology company Forty Seven for $4.9 Billion Gilead Sciences, Inc. and Forty Seven, Inc. announced that
Read more
Vifor Pharma and Janssen partner to commercialise Invokana in the US
Vifor Pharma, headquartered in Switzerland, announced it has partnered with Janssen Pharmaceuticals to co-market Invokana (canagliflozin) in the United States.
Read more